Immunology of cancer stem cells in solid tumours. A review

European Journal of Cancer

Volumn 50, Issue 3, 2014, Pages 649-655

  MacCalli, Cristina ^a   Volontè, Andrea ^a   Cimminiello, Carolina ^a   Parmiani, Giorgio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cancer stem cells; Colorectal carcinoma; Glioblastoma; Immunogenicity; Immunosuppression

Indexed keywords

CYTOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TUMOR ANTIGEN;

ANTIGEN PRESENTATION; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER STEM CELL; CLINICAL PROTOCOL; CYTOKINE RELEASE; DOWN REGULATION; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOGENICITY; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; REVIEW; SOLID TUMOR; TUMOR CELL; TUMOR INITIATING CELL;

CANCER STEM CELLS; COLORECTAL CARCINOMA; GLIOBLASTOMA; IMMUNOGENICITY; IMMUNOSUPPRESSION;

ANIMALS; CELL DIFFERENTIATION; HUMANS; IMMUNOTHERAPY; NEOPLASMS; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 84893642085     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.11.014     Document Type: Review

References (92)

1. L. Vezzoni, and G. Parmiani Limitations of the cancer stem cell theory Cytotechnology 2008 10.1007/s10616-0089166-8
2. L. Ricci-Vitiani, E. Fabrizi, E. Palio, and R. De Maria Colon cancer stem cells J Mol Med 87 2009 1097 1104
3. H. Clevers The cancer stem cell: premises, promises and challenges Nat Med 17 2011 313 319
4. M. Maugeri-Saccà, P. Vigneri, and R. De Maria Cancer stem cells and chemosensitivity Clin Cancer Res 17 2011 4942 4947
5. J.E. Dirck Stem cell concepts renew cancer research Blood 112 2008 4793 4807
6. D. Lu, S. Chen, and X. Tan et al. Fra-1 promotes breast cancer chemosensitivity by driving cancer stem cells from dormancy Cancer Res 72 2012 3451 3456
7. L. Li, and R. Bhatia Stem cell quiescence Clin Cancer Res 17 2011 4936 4941
8. M.G. Francipane, M.P. Alea, and Y. Lombardo et al. Crucial role of interleukin-4 in the survival of colon cancer stem cells Cancer Res 68 2008 4022 4025
9. S. Bao, Q. Wu, and Z. Li et al. Targeting cancer stem cells through L1CAM suppresses glioma growth Cancer Res 68 2008 6043 6048
10. M. Dihen, and M.F. Clarke Cancer stem cells and radiotherapy: new insights into tumor radioresistance J Natl Cancer Inst 98 2006 1755 1757
11. D.K. Irvin, E. Jouanneau, and G. Duvall et al. T cells enhance stem-like properties and conditional malignancy in gliomas PLoS One 5 6 2010 e10974
12. E. Elleback, M.H. Andersen, and I.M. Svane et al. Immunotherapy for metastatic colorectal cancer: present status and new options Scand J Gastroenterol 47 2012 315 324
13. Kalluri, and Weinberg The basics for epithelial-mesenchymal transition J Clin Invest 119 2009 1420 1428
14. J.A. Magee, E. Piskounova, and S.J. Morrison Cancer stem cells: impact, heterogeneity and uncertainty Cancer Cell 21 2012 283 296
15. T. Lapidot, C. Sirard, and J. Vormoor A cell initiating human myeloid leukemia after transplantation into SCID mice Nature 367 1994 645 648
16. D. Bonnet, and J.E. Dick Human acute myeloid leukemia is organized as hierarchy that originates from a primitive hematopoietic cell Nat Med 3 1997 730 737
17. W. Du, X.E. Li, and J. Sipple et al. Overexpression of IL-3Ralpha on CD34+CD38- stem cells defines leukemia-initiating cells in Fanconi anemia AML Blood 117 2011 4243 4252
18. E.H. Huang, M.J. Hynes, and T. Zhang et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colon stem cells (SC) and tracks SC overpopulation during colon tumorigenesis Cancer Res 69 2009 3382 3389
19. J.M. Gerber, B.D. Smith, and B. Ngwang et al. A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia Blood 119 2012 3571 3577
20. R.W. Cho, and M.F. Clarke Recent advances in cancer stem cells Curr Opin Genet Dev 18 2008 48 53
21. Y. Wakamatsu, N. Sakamoto, and H.Z. Oo et al. Expression of cancer stem cell markers ALDH1, CD44, and CD133 in primary tumor and lymph node metastasis of gastric cancer Pathol Int 62 2012 112 119
22. Y. Luo, K. Dallaglio, and Y. Chen et al. ALDH1Aisozymes are markers of human melanoma stem cells and potential therapeutic targets Stem cells 30 2012 2100 2113
23. S.K. Singh, I.D. Hawkins, and J.A. Clarke et al. Identification of human brain tumor initiating cells Nature 432 2004 396 401
24. M. Schneider, J. Huber, and B. Hadachik et al. Characterization of colon cancer cells: a functional approach characterizing CD133 as a potential stem cell marker BMC Cancer 12 2012 96
25. P.C. Hermann, S.L. Huber, and T. Herrler et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cells Cell Stem Cells 1 2007 313 323
26. V. Tirino, R. Camerlingo, and R. Franco et al. The role of CD133 in the identification and characterisation of tumor-initiating cells in non-small-cell lung cancer Eur J Cardiothorac Surg 36 2009 446 453
27. M.D. Curley, V.A. Therrien, and C.L. Cummings et al. CD133 expression defines a tumor initiating cell population in primary human ovarian cancer Stem Cells 27 2009 2875 2883
28. A.T. Collins, P.A. Berry, and C. Hyda et al. Prospective identification of tumorigenic prostate cancer stem cells Cancer Res 65 2005 10946 10951
29. Y. Chen, D. Yu, and H. Zhang et al. CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells Int J Biol Sci 8 2012 992 1004
30. P. Dalerba, S.J. Dylla, and I.K. Park et al. Phenotypic characterization of human colorectal cancer stem cells Proc Natl Acad Sci U S A 104 2008 10158 10163
31. C. Li, D.G. Heidt, and P. Dalerba et al. Identification of pancreatic stem cells Cancer Res 67 2007 1030 1037
32. V. Saini, C.D. Hose, and A. Monks et al. Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma PLoS One 7 2012 e41401
33. K. Kemper, M.R. Sprick, and M. de Bree et al. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation Cancer Res 70 2010 719 729
34. M. Al Hajj, M.S. Wicha, and B. Benito-Hernandez Prospective identification of tumorigenic breast cancer cells Proc Natl Acad Sci U S A 100 2003 3983 3988
35. T. Schatton, G.F. Murphy, and N.Y. Frank et al. Identification of cells initiating human melanomas Nature 451 2008 345 349
36. L. Du, H. Wang, and L. He et al. CD44 is of functional importance for colorectal cancer stem cells Clin Cancer Res 14 2008 6751 6760
37. M.R. Clay, M. Tabor, and J.H. Owen et al. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde hydrogenase Head Neck 32 2010 1195 1201
38. D. Choi, H.W. Lee, and K.Y. Hur et al. Cancer stem cell markers CD133 and CD24correlate with invasiveness and differentiation in colorectal adenocarcinoma World J Gastroenterol 15 2009 2258 2264
39. W.C. Zhang, N. Shy-Chang, and H. Yang et al. Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis Cell 148 2012 259 272
40. Y.C. Wang, Y.T. Yo, and H.Y. Lee et al. ALDH1-bright epithelial ovarian cancer cells are associated with CD44 expression, drug resistance, and poor clinical outcome Am J Pathol 180 2012 1159 1169
41. Z.F. Yang, D.W. Ho, and M.N. Ng et al. Significance of CD90+ cancer stem cells in human liver cancer Cancer Cells 13 2008 153 166
42. Y. Kong, S. Yoshida, and Y. Saito et al. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewed capacity in human B-precursor ALL Leukemia 22 2008 1207 1213
43. Nishizawa et al. HSP DNAJB8 controls tumor-initiating ability in renal cancer stem-like cells Cancer Res 2012 72 2012 2844 2854
44. Y. Li, and J. Laterra Cancer stem cells: distinct entities or dynamically regulated phenotypes? Cancer Res 72 2012 576 580
45. J.M. Rosen, and C.T. Jordan The increasing complexity of the cancer stem cell paradigm Science 324 2009 1670 1673
46. N. Takeda, R. Jain, and M.R. LeBoef Interconversion between intestinal stem cell populations in distinct niches Science 334 2011 1420 1424
47. A. Roesch, M. Fukunaga-Calabis, and E.C. Schmidt et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth Cell 141 2010 583 594
48. Y. Kim, G. Wu, and P. Hamerlik et al. Aptamer identification of brain tumor-initiating cells Cancer Res 73 2013 4923 4946
49. Y. Tu, X. Gao, and G. Li et al. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1 Cancer Res 73 2013 6046 6055
50. S.A. Mani, W. Guo, and M.J. Liao et al. The epithelial-mesenchymal transition generates cells with properties of stem cells Cell 133 2008 704 715
51. M. Podberezin, J. Wen, and C.C. Chang Cancer stem cells: a review of potential clinical applications Arch Pathol Lab Med 2012 [Epub ahead of print]
52. Y. Li, A. Li, and M. Glas et al. C-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype Proc Natl Acad Scie U S A 108 2011 9951 9956
53. A.B. Hjelmeland, and S.N. Rich The quest for self-identity: not all cancer stem cells are the same Clin Cancer Res 18 2012 3495 3498
54. M. Zorniak, P.A. Clark, and H.E. Leeper et al. Differential expression of 2′,3′-cyclic nucleotide 3′-phosphodiesterase and neural lineage markers correlate with glioblastoma xenograft infiltration and patient survival Clin Cancer Res 18 2012 3628 3636
55. T. Di Tomaso, S. Mazzoleni, and E. Wang et al. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients Clin Cancer Res 16 2010 800 813
56. T. Schatton, U. Schutte, and N.Y. Frank et al. Modulation of T-cell activation by malignant melanoma initiating cells Cancer Res 70 2010 697 708
57. J. Wei, J. Barr, and L.-Y. Kong et al. Glioma-associated cancer-initiating cells induce immunosuppression Clin Cancer Res 16 2010 461 473
58. C. Lottaz, D. Beier, and C. Mayer et al. Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin Cancer Res 70 2010 2030 2040
59. K. Le Blanc, C. Tammik, and K. Rosendhal et al. Expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells Exp Hematol 31 2003 890 896
60. T. Schatton, and M.H. Frank Antitumor immunity and cancer stem cells Ann N Y Acad Sci 1176 2009 154 169
61. S.-Y. Kim, H.-S. Cho, and S.-H. Yang et al. Soluble mediators from human neural stem cells play a critical role in suppression of T-cell activation and proliferation J Neurosci Res 87 2009 2264 2272
62. A. Tsuyada, A. Chow, J. Wu, G. Somlo, P. Chu, S. Loera, T. Luu, A.X. Li, X. Wu, W. Ye, S. Chen, W. Zhou, Y. Yu, Y.Z. Wang, X. Ren, H. Li, Y. Kuroki, and S.E. Wang CCL-2-Mediates cross-talk between cancer cells and sromal fibroblats that regulates breast cancer stem cells Cancer Res 72 2012 2768 2779
63. G. Parmiani, V. Russo, and A. Marrari et al. Universal and stemness-related tumor antigens: potential use in cancer immunotherapy Clin Cancer Res 13 2007 5675 5679
64. K. Engelmann, H. Shen, and O.J. Finn MCF7side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1 Cancer Res 68 2008 2419 2426
65. Y. Hirohashi, and T. Torigoe Cytotoxic T lymphocytes. Sniping cancer stem cells Oncoimmunology 1 1 2012 123 125
66. N.H. Segal, D.W. Parsons, and K.S. Peggs et al. Epitope landscape in breast and colorectal cancer Cancer Res 68 2008 889 892
67. Pleasance ED, Cheetham RK, Stephens PI, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature. doi: o8658/doi10.1038.
68. C. Gedye, J. Quirk, and J. Browning et al. Cancer/testis antigens can be immunological targets in clonogenic CD133 melanoma cells Cancer Immunol Immunother 58 2009 1635 1646
69. J. Koshio, H. Kagamu, and K. Nozaki et al. DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked is an immunogenic target of cancer stem cells Cancer Immunol Immunother 62 2013 1619 1628
70. A.D. Boiko, O.V. Razorenova, and M. Van de Rij et al. Human-melanoma initiating cells express neural crest nerve growth factor receptor CD271 Nature 466 2010 10.1038/nature09161
71. C.E. Brown, R. Starr, and B. Aguilar et al. Stem-like tumor-initiating cells isolated from IL13Ralpha2 expressing gliomas are targeted and killed by IL-13-zetakine-redirected T cells Clin Cancer Res 18 2012 2199 2209
72. M. Schmitz, A. Temme, and V. Senner et al. Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy Br J Cancer 96 2007 1293 1301
73. W. Hua, Y. Yao, and Y. Chu et al. The CD133+ tumor stem-like cells-associated antigens may elicit highly intense immune response against human malignant glioma J Neurooncol 105 2011 149 157
74. S. Inoda, Y. Hirohashi, and T. Torigoe et al. Cytotoxic T lymphocytes efficiently recognize human colon cancer stem-like cells Am J Pathol 178 2011 1805 1813
75. M. Mitra, M. Kandalam, and A.S. Harilal et al. EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell mediated immunotherapy Mol Vis 18 2012 290 308
76. T. Forshew, M. Murtaza, and C. Parkinson et al. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA Sci Transl Med 4 2012 136ra68
77. R.A. Morgan, L.A. Johnson, and J.L. Davis et al. Recognition of glioma stem cells by genetically modified T cells targeting EGFRvIII and development of adoptive cell therapy for glioma Hum Gene Ther 23 2012 1043 1053
78. T. Avril, E. Vauleon, and A. Hamlat et al. Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells Brain Pathol 22 2012 159 174
79. M. Todaro, M. D'Asaro, and N. Caccamo et al. Efficient killing of human colon cancer stem cells by γσT lymphocytes J Immunol 182 2009 7287 7296
80. R. Tallerico, M. Todaro, and S. Di Franco et al. Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules J Immunol 190 2013 2381 2390
81. G. Pietra, C. Manzini, and M. Viale et al. Natural killer cells kill human melanoma cells with characteristics of cancer stem cells Int Immunol 21 2009 793 801
82. D. Lai, F. Wang, and Y. Chen et al. Human ovarian cancer stem cells can be efficiently killed by γσT lymphocytes Cancer Immunol Immunother 61 2012 979 989
83. N. Ning, Q. Pan, and F. Zheng et al. Cancer stem cell vaccination confers significant antitumor immunity Cancer Res 72 2012 1853 1864
84. C. Visus, Y. Wang, and A. Lozano-Leon et al. Targeting ALDH (bright) human carcinoma-initiating cells with ALDH1A1-specific CD8+ T cells Clin Cancer Res 17 2011 6174 6184
85. S. Glennie, I. Soeiro, and P.J. Dyson Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells Blood 105 2005 2821 2827
86. S. Beyth, Z. Borovsky, and D. Mevorach et al. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness Blood 105 2005 2214 2219
87. P. Roth, M. Junker, and M. Tritschler et al. GDF-15 contributes to proliferation and immune escape of malignant gliomas Clin Cancer Res 16 2010 3851 3859
88. K.H. Noh, Y.-H. Lee, and J.-H. Jeon Cancer vaccination drives nanog-dependent evolution of tumor cells toward an immune-resistant and stem-like phenotypes Cancer Res 72 2012 1717 1727
89. low breast cancer stem cells Cancer Res 69 2009 8058 8066
90. J. Tao, B. Qiu, and Zhang et al. Expression levels of Fas/FasL mRNA in human brain glioma stem cells Mol Med Rep 5 2012 1202 1206
91. C. Schmidt Cancer stem cells in the crosshairs Cancer Discov 2 2012 384
92. O. Kepp, L. Galluzzi, and I. Martins et al. Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy Cancer Metastasis Rev 30 2011 61 69